Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 26, 2018 08:00 ET | Source: Kalytera Therapeutics, Inc.

Kalytera Therapeutics Announces Filing of Amended and Restated Short Form Prospectus

/NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ SAN FRANCISCO and TEL AVIV, Israel, July 26, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (the "Company", or...
July 10, 2018 08:00 ET | Source: Kalytera Therapeutics, Inc.

Kalytera Therapeutics Announces Short Form Prospectus Offering of Units

/NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ SAN FRANCISCO and TEL AVIV, Israel, July 10, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (the "Company", or...
June 29, 2018 11:31 ET | Source: Kalytera Therapeutics, Inc.

Kalytera Announces Appointment of Victoria Rudman as Interim Chief Financial Officer and Additional Payments in Shares under Payments Agreements with Salzman Group

SAN FRANCISCO and TEL AVIV, Israel, June 29, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the "Company" or "Kalytera") today announced the appointment of...
June 15, 2018 14:55 ET | Source: Kalytera Therapeutics, Inc.

Kalytera Announces Second Payments Agreement with The Salzman Group of Israel

SAN FRANCISCO and TEL AVIV, Israel, June 15, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the "Company" or "Kalytera") today announced that it has entered...
June 04, 2018 14:01 ET | Source: Kalytera Therapeutics, Inc.

Kalytera Announces Next Monthly Payment in Shares under Services Agreement with Salzman Group

SAN FRANCISCO and TEL AVIV, Israel, June 04, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the "Company" or "Kalytera") today announced that the Company has...
April 20, 2018 15:08 ET | Source: Kalytera Therapeutics, Inc.

Kalytera Announces Next Payment in Shares under Services Agreement with Salzman Group

SAN FRANCISCO and TEL AVIV, Israel, April 20, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the "Company" or "Kalytera") today announced that the Company has...
March 22, 2018 09:00 ET | Source: Kalytera Therapeutics, Inc.

Kalytera Announces Next Issuance of Shares under Services Agreement with Salzman Group

SAN FRANCISCO and TEL AVIV, Israel, March 22, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the "Company" or "Kalytera") today announced that the Company...
March 14, 2018 08:30 ET | Source: Kalytera Therapeutics, Inc.

Kalytera Announces Grant of Stock Options to Chief Scientific Officer and Chief Medical Officer

SAN FRANCISCO and TEL AVIV, Israel, March 14, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the "Company" or "Kalytera") today announced that it has granted...
February 23, 2018 08:23 ET | Source: Kalytera Therapeutics, Inc.

Kalytera Announces Further Issuance of Shares under Services Agreement with Salzman Group

SAN FRANCISCO and TEL AVIV, Israel, Feb. 23, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the "Company" or "Kalytera") today announced that the Company has...
January 31, 2018 08:00 ET | Source: Kalytera Therapeutics, Inc.

Kalytera Announces Grant of Stock Options

SAN FRANCISCO and TEL AVIV, Israel, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the "Company" or "Kalytera") today announced that it has granted...